The Rundown — October 5, 2026

THE WORLD · OCTOBER 5, 2026

What's going on right now, in one place. The ↗ links out to the original source; the item's own text turns into a link only once it becomes a full entry here.

The world

• About 200 people are under observation in Russia's Irkutsk region after an Anti-Plague Institute lab worker died of what officials call "pneumonia of unknown etiology"; the WHO says no cause is officially confirmed and the risk to the general public appears low, and no contact has been reported sick. ↗
• Brazil's presidential race heads to an October 25 runoff after Sunday's first round, with Senator Flávio Bolsonaro edging ahead of incumbent Luiz Inácio Lula da Silva 47% to 45% with more than 99% of votes counted. ↗
• Russia struck a bridge in Kyiv on October 4 as German Chancellor Friedrich Merz made an unannounced visit to the Ukrainian capital, with air-raid sirens sounding during his trip. ↗

Science

• The 2026 Nobel Prize in Physiology or Medicine was awarded today to Karl Deisseroth, Peter Hegemann and Georg Nagel for discovering light-gated ion channels, the basis of optogenetics, which lets researchers switch individual brain cells on and off with light. ↗
• NASA astronaut Jessica Watkins commanded SpaceX's Crew-13 to the International Space Station on October 1 aboard Dragon Grace, becoming the first active NASA astronaut to fly twice on a Dragon spacecraft, for a planned six-month stay. ↗

Technology

• Google released Gemini 4 Argon on September 30 in a limited rollout to vetted cybersecurity teams, with the model beating GPT-6 Astra and Claude Opus 5.5 on 13 of 19 of Google's own benchmarks and posting a 15% hallucination rate versus Astra's 51%. ↗
• OpenAI unveiled GPT-6.1 Sol at its September 29 DevDay, pricing it at roughly a fifth of GPT-6 Astra's tokens while cutting its factual-error rate from 11.4% to 7.7%, days after reports it had shelved a more capable Astra successor over its own safety-test results. ↗

Health & medicine

• The FDA approved AbbVie's Juvmo (tavapadon) on September 28 as the first selective D1/D5 receptor agonist for adult Parkinson's disease, taken once daily with or without levodopa. ↗
• A multinational study presented at EADV 2026 found nail detachment in 39% of 575 GLP-1 users versus 9% of 1,329 matched non-users, the first controlled look at the drugs' effect on nail health. ↗

Bitcoin & crypto

• Bitcoin traded around $86,377 on CoinDesk's index early Monday, up about 2% on the day but still roughly a third below the $126,210.50 all-time high it set almost exactly a year ago. ↗

Business / macro & markets

• Wall Street closed out last week higher — the Dow up 0.5% to 51,176.96, the S&P 500 up 0.7% to 7,722.72, the Nasdaq up 1.2% to 27,190.86 — before futures slipped Monday morning on rising bond yields and eurozone jitters. ↗
• The Kobeissi Letter reports that shipping 2 million barrels of crude from West Africa to China now costs $27.22 a barrel, up from about $6.50 in July (+319%), as buyers scramble for physical crude with the Strait of Hormuz still closed; the freight figure is the newsletter's own and we haven't confirmed it independently. ↗